2’-β-C-Ethynylcytidine

目录号: HY-152474: FAQs
Data Sheet 产品使用指南

摩尔计算器

2’-β-C-Ethynylcytidine 是一种嘌呤核苷类似物。嘌呤核苷类似物具有广泛的抗肿瘤活性，靶向惰性淋巴系统恶性肿瘤。这一过程中的抗癌机制依赖于抑制 DNA 合成，诱导细胞凋亡 (apoptosis) 等。2’-β-C-Ethynylcytidine 是一种点击化学试剂。它含有 Alkyne 基团，可以和含有 Azide 基团的分子发生铜催化的叠氮-炔环加成反应 (CuAAc)。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

2’-β-C-Ethynylcytidine Chemical Structure

CAS No. : 188413-99-2

1. 客户无需承担相应的运输费用。

2. 同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

可免费申领三个不同产品的试用装。

3. 试用装只面向终端客户。

规格		是否有货
50 mg		询价
100 mg		询价
250 mg		询价

or 大包装询价

* Please select Quantity before adding items.

Customer Review

2’-β-C-Ethynylcytidine 相关产品

•同靶点产品:

•同靶点蛋白产品:

生物活性
纯度 & 产品资料
参考文献

生物活性

2’-β-C-Ethynylcytidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc^[1]. 2’-β-C-Ethynylcytidine is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

细胞效力
(Cellular Effect)

Cell Line	Type	Value	Description	References
A549	CC₅₀	> 100 μM Compound: 13	Cytotoxicity against human A549 cells assessed as intracellular ATP level by Celltiter-Glo luminescent assay Cytotoxicity against human A549 cells assessed as intracellular ATP level by Celltiter-Glo luminescent assay	[PMID: 20457821]
A549	EC₅₀	> 100 μM Compound: 13	Antiviral activity against at 0.3 MOI Dengue virus 2 infected in human A549 cells assessed as level of E protein after 48 hrs by ELISA Antiviral activity against at 0.3 MOI Dengue virus 2 infected in human A549 cells assessed as level of E protein after 48 hrs by ELISA	[PMID: 20457821]
BHK-21	EC₅₀	> 100 μM Compound: NM176	Antiviral activity against YFV infected in BHK-21 cells assessed as inhibition of virus-induced cytopathogenicity after 3 to 4 days by MTT assay Antiviral activity against YFV infected in BHK-21 cells assessed as inhibition of virus-induced cytopathogenicity after 3 to 4 days by MTT assay	[PMID: 26443549]
BHK-21	EC₅₀	> 100 μM Compound: NM176	Antiviral activity against Reo-1 virus infected in BHK-21 cells assessed as inhibition of virus-induced cytopathogenicity after 3 to 4 days by MTT assay Antiviral activity against Reo-1 virus infected in BHK-21 cells assessed as inhibition of virus-induced cytopathogenicity after 3 to 4 days by MTT assay	[PMID: 26443549]
KB	IC₅₀	> 350 μM Compound: 55	Concentration required to inhibit 50% of human epidermoid KB cell growth was measured(in vitro) using MTT assay. Concentration required to inhibit 50% of human epidermoid KB cell growth was measured(in vitro) using MTT assay.	[PMID: 9667977]
L1210	IC₅₀	> 350 μM Compound: 55	Concentration required to inhibit 50% of murine leukemia L1210 cell growth was measured(in vitro) using MTT assay. Concentration required to inhibit 50% of murine leukemia L1210 cell growth was measured(in vitro) using MTT assay.	[PMID: 9667977]
MT4	CC₅₀	> 100 μM Compound: NM176	Cytotoxicity against human MT4 cells assessed as cell viability after 96 hrs by MTT assay Cytotoxicity against human MT4 cells assessed as cell viability after 96 hrs by MTT assay	[PMID: 26443549]
MT4	CC₅₀	≥ 100 μM Compound: NM 176	Cytotoxicity against human MT4 cells after 96 hrs by MTT assay Cytotoxicity against human MT4 cells after 96 hrs by MTT assay	[PMID: 20359898]
Vero	CC₅₀	> 100 μM Compound: 2'-EtynCyt	Cytotoxicity against african green monkey Vero 76 cells after 48 to 96 hrs by crystal violet staining Cytotoxicity against african green monkey Vero 76 cells after 48 to 96 hrs by crystal violet staining	[PMID: 22047799]
Vero	CC₅₀	> 100 μM Compound: 2'-C-ethynyl-cytidine	Cytotoxicity against african green monkey Vero 76 cells after 48 to 96 hrs by MTT assay Cytotoxicity against african green monkey Vero 76 cells after 48 to 96 hrs by MTT assay	[PMID: 22513121]
Vero	EC₅₀	> 100 μM Compound: NM 176	Antiviral activity against HSV1 KOS infected in african green monkey Vero cells after 3 days by plaque reduction assay Antiviral activity against HSV1 KOS infected in african green monkey Vero cells after 3 days by plaque reduction assay	[PMID: 20359898]
Vero	EC₅₀	> 100 μM Compound: NM 176	Antiviral activity against Vaccinia virus Elstree-Lister infected in african green monkey Vero cells after 3 days by plaque reduction assay Antiviral activity against Vaccinia virus Elstree-Lister infected in african green monkey Vero cells after 3 days by plaque reduction assay	[PMID: 20359898]
Vero	EC₅₀	> 100 μM Compound: NM 176	Antiviral activity against RSV A2 infected in african green monkey Vero cells after 5 days by plaque reduction assay Antiviral activity against RSV A2 infected in african green monkey Vero cells after 5 days by plaque reduction assay	[PMID: 20359898]
Vero	EC₅₀	18 μM Compound: NM176	Antiviral activity against Human poliovirus 1 strain Sabin infected African green monkey Vero 76 cells assessed as reduction in plaque number treated after viral infection measured after 2 days by plaque reduction assay Antiviral activity against Human poliovirus 1 strain Sabin infected African green monkey Vero 76 cells assessed as reduction in plaque number treated after viral infection measured after 2 days by plaque reduction assay	10.1007/s00044-012-0342-1
Vero	EC₅₀	23 μM Compound: 2'-EtynCyt	Antiviral activity against Human poliovirus 1 strain Sabin Chat infected in african green monkey Vero 76 cells assessed as virus-induced reduction of plaque formation after 2 days using crystal violet staining Antiviral activity against Human poliovirus 1 strain Sabin Chat infected in african green monkey Vero 76 cells assessed as virus-induced reduction of plaque formation after 2 days using crystal violet staining	[PMID: 22047799]
Vero	EC₅₀	23 μM Compound: NM 176	Antiviral activity against Polio virus type1 Sabin strain Chat infected in african green monkey Vero cells after 2 days by plaque reduction assay Antiviral activity against Polio virus type1 Sabin strain Chat infected in african green monkey Vero cells after 2 days by plaque reduction assay	[PMID: 20359898]
Vero	EC₅₀	23 μM Compound: NM176	Antiviral activity against Human coxsackievirus B2 infected in African green monkey Vero 76 cells assessed as reduction in plaque number treated after viral infection measured after 3 days by plaque reduction assay Antiviral activity against Human coxsackievirus B2 infected in African green monkey Vero 76 cells assessed as reduction in plaque number treated after viral infection measured after 3 days by plaque reduction assay	10.1007/s00044-012-0342-1
Vero	EC₅₀	27 μM Compound: 2'-EtynCyt	Antiviral activity against Human coxsackievirus B5 Ohio-1 infected in african green monkey Vero 76 cells assessed as reduction of virus-induced plaque formation after 3 days using crystal violet staining Antiviral activity against Human coxsackievirus B5 Ohio-1 infected in african green monkey Vero 76 cells assessed as reduction of virus-induced plaque formation after 3 days using crystal violet staining	[PMID: 22047799]
Vero	EC₅₀	27 μM Compound: NM 176	Antiviral activity against Human coxsackievirus B2 Ohio-1 infected in african green monkey Vero cells after 3 days by plaque reduction assay Antiviral activity against Human coxsackievirus B2 Ohio-1 infected in african green monkey Vero cells after 3 days by plaque reduction assay	[PMID: 20359898]
Vero 76	CC₅₀	> 100 μM Compound: 2'-EtynCyt	Cytotoxicity against mock-infected african green monkey Vero 76 cells assessed as reduction in cell viability after 48 to 96 hrs by MTT assay Cytotoxicity against mock-infected african green monkey Vero 76 cells assessed as reduction in cell viability after 48 to 96 hrs by MTT assay	[PMID: 27161176]
Vero 76	CC₅₀	> 100 μM Compound: Eth-Cyt	Cytotoxicity against mock-infected African green monkey Vero 76 cells assessed as reduction in proliferation after 48 to 96 hrs by MTT method Cytotoxicity against mock-infected African green monkey Vero 76 cells assessed as reduction in proliferation after 48 to 96 hrs by MTT method	[PMID: 25014745]
Vero 76	EC₅₀	> 100 μM Compound: Eth-Cyt	Antiviral activity against CVB-5 virus Faulkner ATCC VR-185 infected in african green monkey Vero-76 cells after 3 days by plaque reduction assay Antiviral activity against CVB-5 virus Faulkner ATCC VR-185 infected in african green monkey Vero-76 cells after 3 days by plaque reduction assay	[PMID: 26479028]
Vero 76	CC₅₀	> 100 μM Compound: NM176	Cytotoxicity against african green monkey Vero 76 cells assessed as cell viability after 48 to 96 hrs by crystal violet staining method Cytotoxicity against african green monkey Vero 76 cells assessed as cell viability after 48 to 96 hrs by crystal violet staining method	[PMID: 26443549]
Vero 76	EC₅₀	> 100 μM Compound: NM176	Antiviral activity against human RSV infected in african green monkey Vero76 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by plaque reduction assay Antiviral activity against human RSV infected in african green monkey Vero76 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by plaque reduction assay	[PMID: 26443549]
Vero 76	EC₅₀	18 μM Compound: NM 176	Antiviral activity against Human poliovirus 1 strain Sabin infected African green monkey Vero76 cells assessed as reduction of virus-induced plaque reduction after 2 days by MTT assay Antiviral activity against Human poliovirus 1 strain Sabin infected African green monkey Vero76 cells assessed as reduction of virus-induced plaque reduction after 2 days by MTT assay	10.1007/s00044-010-9513-0
Vero 76	EC₅₀	23 μM Compound: 2'-C-ethynyl-cytidine	Antiviral activity against Polio virus type 1 strain sabin ATCC VR-1562 infected in african green monkey Vero-76 cells assessed as reduction in viral plaque after 2 days by crystal violet staining Antiviral activity against Polio virus type 1 strain sabin ATCC VR-1562 infected in african green monkey Vero-76 cells assessed as reduction in viral plaque after 2 days by crystal violet staining	[PMID: 22513121]
Vero 76	EC₅₀	23 μM Compound: NM 176	Antiviral activity against Human coxsackievirus B2 infected African green monkey Vero76 cells assessed as reduction of virus-induced plaque reduction after 3 days by MTT assay Antiviral activity against Human coxsackievirus B2 infected African green monkey Vero76 cells assessed as reduction of virus-induced plaque reduction after 3 days by MTT assay	10.1007/s00044-010-9513-0
Vero 76	EC₅₀	23 μM Compound: 2'-EtynCyt	Antiviral activity against Human poliovirus 1 strain Sabin infected in Vero 76 cells after 2 days by crystal violet staining based plaque reduction assay Antiviral activity against Human poliovirus 1 strain Sabin infected in Vero 76 cells after 2 days by crystal violet staining based plaque reduction assay	[PMID: 27161176]
Vero 76	EC₅₀	23 μM Compound: Eth-Cyt	Antiviral activity against Poliovirus 1 strain Sabin ATCC VR-1562 infected in Vero 76 cells after 2 days by plaque reduction assays Antiviral activity against Poliovirus 1 strain Sabin ATCC VR-1562 infected in Vero 76 cells after 2 days by plaque reduction assays	[PMID: 25014745]
Vero 76	EC₅₀	23 μM Compound: Eth-Cyt	Antiviral activity against RSVA2 ATCC VR-1540 infected in african green monkey Vero-76 cells after 5 days by plaque reduction assay Antiviral activity against RSVA2 ATCC VR-1540 infected in african green monkey Vero-76 cells after 5 days by plaque reduction assay	[PMID: 26479028]
Vero 76	EC₅₀	25 μM Compound: NM176	Antiviral activity against Human poliovirus 1 Sabin infected in african green monkey Vero76 cells assessed as inhibition of virus-induced cytopathogenicity by plaque reduction assay Antiviral activity against Human poliovirus 1 Sabin infected in african green monkey Vero76 cells assessed as inhibition of virus-induced cytopathogenicity by plaque reduction assay	[PMID: 26443549]
Vero 76	EC₅₀	27 μM Compound: 2'-C-ethynyl-cytidine	Antiviral activity against Coxsackie virus type B5 Ohio-1 ATCC VR-29 infected in african green monkey Vero-76 cells assessed as reduction in viral plaque after 3 days by crystal violet staining Antiviral activity against Coxsackie virus type B5 Ohio-1 ATCC VR-29 infected in african green monkey Vero-76 cells assessed as reduction in viral plaque after 3 days by crystal violet staining	[PMID: 22513121]
Vero 76	EC₅₀	27 μM Compound: Eth-Cyt	Antiviral activity against Human poliovirus 1 strain Sabin 1 virus infected in african green monkey Vero-76 cells after 2 days by plaque reduction assay Antiviral activity against Human poliovirus 1 strain Sabin 1 virus infected in african green monkey Vero-76 cells after 2 days by plaque reduction assay	[PMID: 26479028]
Vero 76	EC₅₀	27 μM Compound: 2'-EtynCyt	Antiviral activity against CVB-2 infected in Vero 76 cells after 3 days by crystal violet staining based plaque reduction assay Antiviral activity against CVB-2 infected in Vero 76 cells after 3 days by crystal violet staining based plaque reduction assay	[PMID: 27161176]
Vero 76	EC₅₀	27 μM Compound: Eth-Cyt	Antiviral activity against Coxsackievirus B5 Faulkner (ATCC VR-185) infected in Vero 76 cells after 3 days by plaque reduction assays Antiviral activity against Coxsackievirus B5 Faulkner (ATCC VR-185) infected in Vero 76 cells after 3 days by plaque reduction assays	[PMID: 25014745]
Vero 76	EC₅₀	30 μM Compound: NM176	Antiviral activity against human CVB5 infected in african green monkey Vero76 cells assessed as inhibition of virus-induced cytopathogenicity after 3 days by plaque reduction assay Antiviral activity against human CVB5 infected in african green monkey Vero76 cells assessed as inhibition of virus-induced cytopathogenicity after 3 days by plaque reduction assay	[PMID: 26443549]

分子量

267.24

Formula

C₁₁H₁₃N₃O₅

CAS 号

188413-99-2

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料

产品使用指南 (1538 KB)

参考文献

[1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. [Content Brief]

2’-β-C-Ethynylcytidine 相关分类

摩尔计算器
稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量		浓度		体积		分子量 *
	=		×		×

The dilution calculator equation

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

浓度 _(start)	×	体积 _(start)	=	浓度 _(final)	×	体积 _(final)
	×		=		×
C1		V1		C2		V2

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

2’-β-C-Ethynylcytidine188413-99-2Nucleoside Antimetabolite/Analogindolent lymphoid malignanciesantitumorInhibitorinhibitorinhibit

您最近查看的产品:

产品名称：

* 需求量：

* 客户姓名：

* Email：

* 电话：

* 公司或机构名称：

留言给我们：

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。	站点地图隐私声明
沪ICP备15051369号-4 上海工商沪公网安备31011502019417 沪(浦)应急管危经许[2021]201709(QFYS) 营业执照（三证合一）
Copyright © 2013-2024 MedChemExpress. All Rights Reserved.

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。

站点地图隐私声明

沪ICP备15051369号-4

上海工商

沪公网安备31011502019417

沪(浦)应急管危经许[2021]201709(QFYS)

营业执照（三证合一）

2’-β-C-Ethynylcytidine

Customer Review

2’-β-C-Ethynylcytidine 相关产品

•同靶点产品:

•同靶点蛋白产品:

生物活性

纯度 & 产品资料

参考文献

2’-β-C-Ethynylcytidine 相关分类

摩尔计算器

稀释计算器

The molarity calculator equation

The dilution calculator equation

Keywords:

您最近查看的产品:

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

产品名称：			* Lot #：
* 客户姓名：			* Email：
电话：			* 部门：
* 公司或机构名称：
留言给我们：

姓名
邮箱 *

Sorry, but the email address you supplied was invalid.

2’-β-C-Ethynylcytidine

Customer Review

2’-β-C-Ethynylcytidine 相关抗体

2’-β-C-Ethynylcytidine 相关产品

•同靶点产品:

•同靶点蛋白产品:

生物活性

纯度 & 产品资料

参考文献

2’-β-C-Ethynylcytidine 相关分类

摩尔计算器

稀释计算器

The molarity calculator equation

The dilution calculator equation

Keywords:

您最近查看的产品:

Request for HNMR Report

Request for HNMR Report

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z